MNV
Market News Video
MNV MNV 10 Stocks Crossing Above Their 200 Day Moving Average
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

Add Up The Parts: XBI Could Be Worth $80
Tuesday, June 28, 9:55 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Noteworthy ETF Outflows: XBI, IONS, ALKS, ICPT
Friday, July 1, 10:56 AM ET, by Market News Video Staff

Symbols mentioned in this story: XBI, IONS, ALKS, ICPT Exchange traded funds (ETFs) trade just ...

Analysts Expect 42% Upside For The Holdings of XBI
Monday, July 11, 8:07 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

SPDR S&P Biotech ETF Experiences Big Inflow
Tuesday, July 12, 11:03 AM ET, by Market News Video Staff

Symbols mentioned in this story: XBI, IONS, TSRO, ALKS Exchange traded funds (ETFs) trade just ...

Short Interest In Neurocrine Biosciences Decreases By 30%
Wednesday, July 13, 2:50 PM ET, by Market News Video Staff

The most recent short interest data has been released for the 06/30/2016 settlement date, which ...

  More articles:  1 2 3 4 5 6 7 next »

NBIX Crosses Below Key Moving Average Level

By Market News Video Staff, Friday, December 21, 4:35 PM ET
Play Video: Learn About The 200 DMA


If the video does not load after a few moments, Upgrade to the Latest Flash Player.

In trading on Friday, shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) crossed below their 200 day moving average of $7.55, changing hands as low as $7.50 per share. Neurocrine Biosciences, Inc. shares are currently trading up about 2.2% on the day. The chart below shows the one year performance of NBIX shares, versus its 200 day moving average:

Neurocrine Biosciences, Inc. 200 Day Moving Average Chart

Looking at the chart above, NBIX's low point in its 52 week range is $6.25 per share, with $9.98 as the 52 week high point that compares with a last trade of $7.92.


Special Offer: Establish a secure stream of income during your retirement years by following the Retiree Income Portfolio with this free 30 day trial

According to the ETF Finder at ETF Channel, NBIX makes up 1.06% of the SPDR S&P Biotech ETF (AMEX:XBI) which is trading lower by about 0.6% on the day Friday.

See what other ETFs contain NBIX
See what other stocks are held by XBI


Top Six Most Viewed Stories This Week @ Market News Video:

This Article's Word Cloud:   AMEX   According   Biosciences   Biotech   Crossing   Establish   Finder   Friday   Income   Looking   NBIX   Neurocrine   Retiree   SPDR   Special   Start   Stocks   Their   about   average   below   changing   chart   compares   currently   during   held   income   last   lower   makes   moving   other   point   range   raquo   retirement   secure   share   shares   slideshow   that   trading   versus   week   what   which   with   years   your
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy - Video Widget
MNV
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Stock Message Boards Stock Market Definitions
MNV

NBIX Crosses Below Key Moving Average Level | Market News Video | Copyright © 2008 - 2016, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.